US2017151276A9PendingUtilityA9
Method and pharmaceutical to treat spinal discs
Est. expiryOct 31, 2020(expired)· nominal 20-yr term from priority
Inventors:Bjorn Eek
A61P 25/00A61K 47/42A61K 31/445A61K 47/24A61K 31/7004A61K 31/726A61K 47/02A61K 9/0019A61K 31/7008A61K 31/737A61K 47/20A61K 47/26A61K 47/36A61P 23/00
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods for reducing chronic pain caused by a disrupted spinal disc are described. In one method, a solution is injected into the disc. The solution includes chondroitin sulphate, glucosamine HCl, and dextrose. The solution may optionally include dimethyl sulfoxide and/or an anesthetic such as bupivicaine.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of reducing chronic pain caused by a disrupted spinal disc comprising the step of injecting a solution into said disc, the solution comprising:
chondroitin sulphate; glucosamine HCl; and dextrose.
2 . The method of claim 1 , further comprising dimethyl sulfoxide.
3 . The method of claim 1 , wherein the solution further comprises an anesthetic.
4 . The method of claim 3 , wherein the anesthetic is bupivicaine.
5 . A method of treating an internal disc disruption comprising the step of injecting a solution into said disc, the solution comprising:
chondroitin sulphate; glucosamine HCl; and dextrose.
6 . The method of claim 5 , further comprising dimethyl sulfoxide.
7 . The method of claim 5 , wherein the solution further comprises an anesthetic.
8 . The method of claim 7 , wherein the anesthetic is bupivicaine.Join the waitlist — get patent alerts
Track US2017151276A9 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.